Adoptive cell therapy (ACT) is an immunotherapy where T cells, for example, tumor-infiltrating lymphocytes (TILs), are grown out from a patient’s tumor or blood, expanded in vitro in the presence of human IL-2, and later infused back into the same patient.20 This evidence concerns the gene IL2 and neoplasm.